-
Conditions
Interventions
A patient who has diabetic retinopathy ,A patient who has cataract,A patient who diagnosed for wet-
age related macular degeneration
Other,Other,Other
Diabetic retionopathy ,Cataract ,Wet-
AMD
Sponsors
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Eligibility
Sex/Gender
All
Age
18 Years to 999 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for DR 1. Type 2 diabetes patient age> 18 years old 2. No other intraocular disease that effect functioning of vision such as primary open angle glaucoma , retinal vascular occlusion , hereditary retina disease , ocular inflammation , central serous chorioretinopathy, macular hole, rhegmatogenous retinal detachment or other disease that interfere vision except diabetic complications: DME, TRD, NVG and VH . ERM without macular hole is included in the study. 3. No cataract more than NS2+/PSC1+/CC2+ 4. No history of Alzheimer’s disease, Dementia or poor mental health status or on current treatment of psychotic/antidepressant medication 5. No history of any ocular surgery within 3 months 6. Native Thai speaking Inclusion criteria for cataract 1. Any cataract age> 18 years old 2. No other intraocular disease that effect functioning of vision such as primary open angle glaucoma , retinal vascular occlusion , hereditary retina disease , ocular inflammation , central serous chorioretinopathy, macular hole, diabetic retinopathy rhegmatogenous retinal detachment, wet-age related macular degeneration or any ocular condition that alter vision except from cataract. 3. No history of Alzheimer’s disease, Dementia or poor mental health status or on current treatment of psychotic/antidepressant medication 4. No history of any ocular surgery within 3 months 5. Native Thai speaking Inclusion criteria for Wet age-related macular degeneration 1. Any wet AMD age> 18 years old 2. No other intraocular disease that effect functioning of vision such as primary open angle glaucoma , retinal vascular occlusion , hereditary retina disease , ocular inflammation , central serous chorioretinopathy, macular hole, diabetic retinopathy rhegmatogenous retinal มDME, TRD, NVG and VH . 3. No cataract more than NS2+/PSC1+/CC2+ 4. No history of Alzheimer’s disease, Dementia or poor mental health status or on current treatment of psychotic/antidepressant medication 5. No history of any ocular surgery within 3 months 6. Native Thai speaking
Exclusion criteria
Exclusion criteria: Exclusion criteria for DR 1. Patient who is not willing to complete the interview or unwilling to answer the question 2. Dense posterior capsular opacity in pseudophakic patient that interfere visual acuity 3. Patient/respondents who indicated for not understand the task on a feasibility questionnaire 4. Patient/respondents who did not differentiate between any of different health states 5. Patient/respondents who did not trade off any time (non -trader) 6. Patient/respondents who use time for each task more than 150% of average time from pilot study Exclusion criteria for cataract 1. Patient who is not willing to complete the interview or unwilling to answer the question 2. Patient/respondents who indicated for not understand the task on a feasibility questionnaire 3. Patient/respondents who did not differentiate between any of different health states 4. Patient/respondents who did not trade off any time (non -trader) 5. Patient/respondents who use time for each task more than 150% of average time from pilot study Exclusion criteria for W AMD 1. Patient who is not willing to complete the interview or unwilling to answer the question 2. Patient/respondents who indicated for not understand the task on a feasibility questionnaire 3. Patient/respondents who did not differentiate between any of different health states 4. Patient/respondents who did not trade off any time (non -trader) 5. Patient/respondents who use time for each task more than 150% of average time from pilot study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health state utility 1 day Time trade off survey | — |
Secondary
| Measure | Time frame |
|---|---|
| Health state utility 1 day HUI3 survey, EQ-5D-5L survey,Visual acuity 1 day modified ETDRS chart ,Dermographic data 1 day interview,Eye examination 1 day Chart recored and imaging | — |
Countries
Thailand
Contacts
Public ContactPear Pongsachareonnont
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University
Outcome results
None listed